Skip to main content

Want a detailed portfolio tracker?

MediWound (MDWD) P/E (2014 - 2026)

MediWound (MDWD) P/E from Mar 20, 2014 to Jul 21, 2026. The TTM MediWound (MDWD) P/E is -6.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MediWound (MDWD)

YearP/EChange
2026-6.32-28.18%
2025-8.80+51.97%
2024-5.79+0.05%
2023-5.79+60.51%
2022-3.61-24.05%
2021-4.75-56.60%
2020-10.94-164.40%
201916.99-116.81%
2018-101.08+2117.90%
2017-4.56+12.91%
2016-4.04-51.89%
2015-8.39+12.78%
2014-7.44N/A

Comparison MediWound (MDWD) P/E with competitors

MediWound (MDWD) P/E is -6.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.18%
FGENFibroGen Inc0.24-103.80%
CHRSCoherus Biosciences Inc0.85-113.42%
FBIOFortress Biotech Inc0.95-115.01%
ORMPOramed Pharmaceuticals Inc1.50-123.77%
AGENAgenus Inc3.01-147.60%
INVAInnoviva Inc3.15-149.89%
VXRTVaxart Inc3.55-156.14%
CRMDCorMedix Inc3.63-157.39%
CVACCureVac N.V.4.45-170.32%
GLPGGalapagos NV4.86-176.85%
SRPTSarepta Therapeutics Inc4.88-177.22%
ABEOAbeona Therapeutics Inc5.39-185.21%
ABUSArbutus Biopharma Corp5.60-188.50%
ZVRAZevra Therapeutics Inc5.89-193.12%
SPROSpero Therapeutics Inc6.23-198.51%
CGENCompugen Ltd6.31-199.87%
RIGLRigel Pharmaceuticals6.87-208.69%
SLXNSilexion Therapeutics Corp7.30-215.40%
OMEROmeros Corporation9.26-246.44%
AUPHAurinia Pharmaceuticals Inc9.58-251.60%
PLXProtalix BioTherapeutics Inc10.89-272.26%
ACADAcadia Pharmaceuticals Inc11.73-285.51%
TBPHTheravance Biopharma Inc12.26-293.95%
ADMAAdma Biologics Inc12.42-296.41%
HRMYHarmony Biosciences Holdings Inc13.82-318.59%
SABSSAB Biotherapeutics Inc14.14-323.59%
NAGENiagen Bioscience Inc14.82-334.37%
INCYIncyte Corp15.82-350.26%
REGNRegeneron Pharmaceuticals Inc15.86-350.80%
PBYIPuma Biotechnology Inc17.32-373.88%
CPRXCatalyst Pharmaceuticals Inc17.44-375.83%
EXELExelixis Inc17.54-377.39%
TGTXTG Therapeutics Inc18.97-399.98%
XOMAXOMA Royalty Corp22.87-461.81%
ARGXArgen X SE24.30-484.32%
CTMXCytomX Therapeutics Inc24.82-492.60%
XOMAOXOMA Royalty Corp25.34-500.88%
HALOHalozyme Therapeutics Inc25.62-505.29%
XOMAPXOMA Royalty Corp25.67-506.03%
VRTXVertex Pharmaceuticals Inc27.99-542.80%
RPRXRoyalty Pharma plc - Class A28.69-553.75%
SLNOSoleno Therapeutics Inc29.02-558.94%
ASNDAscendis Pharma A/S30.09-575.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-699.66%
APLSApellis Pharmaceuticals Inc39.02-717.20%
BMRNBiomarin Pharmaceutical Inc42.21-767.67%
KRYSKrystal Biotech Inc45.34-817.20%
ONCBeiGene Ltd69.54-1199.93%
PHARPharming Group N.V.75.03-1286.69%
TECHBio-Techne Corp101.96-1712.69%
VCELVericel Corp109.92-1838.64%
ALNYAlnylam Pharmaceuticals Inc117.96-1965.87%
GMABGenmab140.29-2319.00%
TLXTelix Pharmaceuticals Ltd162.15-2664.79%
CORTCorcept Therapeutics Inc212.86-3466.80%